Approaches and technologies in male fertility preservation

Mahmoud Huleihel, Eitan Lunenfeld

פרסום מחקרי: פרסום בכתב עתסקירהביקורת עמיתים

21 ציטוטים ‏(Scopus)

תקציר

Male fertility preservation is required when treatment with an aggressive chemo-/-radiotherapy, which may lead to irreversible sterility. Due to new and efficient protocols of cancer treatments, surviving rates are more than 80%. Thus, these patients are looking forward to family life and fathering their own biological children after treatments. Whereas adult men can cryopreserve their sperm for future use in assistance reproductive technologies (ART), this is not an option in prepubertal boys who cannot produce sperm at this age. In this review, we summarize the different technologies for male fertility preservation with emphasize on prepubertal, which have already been examined and/or demonstrated in vivo and/or in vitro using animal models and, in some cases, using human tissues. We discuss the limitation of these technologies for use in human fertility preservation. This update review can assist physicians and patients who are scheduled for aggressive chemo-/radiotherapy, specifically prepubertal males and their parents who need to know about the risks of the treatment on their future fertility and the possible present option of fertility preservation.

שפה מקוריתאנגלית
מספר המאמר5471
עמודים (מ-עד)1-19
מספר עמודים19
כתב עתInternational Journal of Molecular Sciences
כרך21
מספר גיליון15
מזהי עצם דיגיטלי (DOIs)
סטטוס פרסוםפורסם - 1 אוג׳ 2020
פורסם באופן חיצוניכן

טביעת אצבע

להלן מוצגים תחומי המחקר של הפרסום 'Approaches and technologies in male fertility preservation'. יחד הם יוצרים טביעת אצבע ייחודית.

פורמט ציטוט ביבליוגרפי